[HTML][HTML] Global and regional estimates of genital human papillomavirus prevalence among men: a systematic review and meta-analysis

L Bruni, G Albero, J Rowley, L Alemany… - The Lancet Global …, 2023 - thelancet.com
Background The epidemiology of human papillomavirus (HPV) in women has been well
documented. Less is known about the epidemiology of HPV in men. We aim to provide …

Disparities in HPV vaccination rates and HPV prevalence in the United States: a review of the literature

J Hirth - Human vaccines & immunotherapeutics, 2019 - Taylor & Francis
Human papillomavirus (HPV) is a common sexually transmitted infection which is the cause
of several cancers, including cervical cancer, and genital warts. Although cervical cancer …

[HTML][HTML] Prevalence of HPV in adults aged 18-69: United States, 2011-2014

GM McQuillan, D Kruszon-Moran, LE Markowitz… - 2017 - cdc.gov
Products - Data Briefs - Number 280 - April 2017 Skip directly to site content Skip directly to
page options Skip directly to AZ link Centers for Disease Control and Prevention. CDC …

[HTML][HTML] National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2016

TY Walker - MMWR. Morbidity and mortality weekly report, 2017 - cdc.gov
To protect against vaccine-preventable diseases, including human papillomavirus (HPV)–
associated cancers, diphtheria, pertussis, tetanus, and meningococcal disease, routine …

[HTML][HTML] Efficacy, effectiveness and safety of vaccination against human papillomavirus in males: a systematic review

T Harder, O Wichmann, SJ Klug, MAB van der Sande… - BMC medicine, 2018 - Springer
Background Human papillomavirus (HPV) vaccination is safe and effective in preventing
cervical cancer in females. As HPV infections can also induce cancers of the anus, penis …

Human papillomavirus vaccine impact and effectiveness through 12 years after vaccine introduction in the United States, 2003 to 2018

HG Rosenblum, RM Lewis, JW Gargano… - Annals of internal …, 2022 - acpjournals.org
Background: Human papillomavirus (HPV) vaccination was introduced in 2006 for females
and in 2011 for males. Objective: To estimate vaccine impact and effectiveness against …

Prevalence of human papillomavirus among females after vaccine introduction—National Health and Nutrition Examination Survey, United States, 2003–2014

SE Oliver, ER Unger, R Lewis… - The Journal of …, 2017 - academic.oup.com
Background Human papillomavirus (HPV) vaccine was recommended in 2006 for routine
vaccination of US females aged 11–12 years. Most vaccine used through 2014 was …

Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review

W Wang, S Kothari, J Skufca, AR Giuliano… - Expert Review of …, 2022 - Taylor & Francis
Introduction Human papillomavirus (HPV) infection, which poses significant disease burden,
is decreasing following implementation of vaccination programs. Synthesized evidence on …

Transmission and clearance of human papillomavirus infection in the oral cavity and its role in oropharyngeal carcinoma–A review

M Wierzbicka, MRM San Giorgi… - Reviews in medical …, 2023 - Wiley Online Library
The majority of sexually active individuals becomes infected with human papillomavirus
(HPV) at least once in their lifetime. Pathways for HPV transmission vary across different …

Population-based HPV vaccination programmes are safe and effective: 2017 update and the impetus for achieving better global coverage

JML Brotherton, PN Bloem - Best practice & research Clinical obstetrics & …, 2018 - Elsevier
Persistent oncogenic human papillomavirus (HPV) is the cause of cervical cancer, as well as
cancers of the anus, penis, vulva, vagina and oropharynx. There is good evidence that …